Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.39 USD | +1.61% | +3.75% | -4.02% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.02% | 3.63B | |
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics, Inc. Appoints David Marek as Chief Commercial Officer, Effective August 31, 2019